George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close update

10 Feb 2020 07:00

RNS Number : 4117C
Watchstone Group PLC
10 February 2020
 

Watchstone Group plc

 

("Watchstone" or the "Group")

 

Pre-close update

 

Watchstone Group plc (LON:WTG) today issues a pre-close update ahead of its results for the year ended 31 December 2019.

 

During 2019, the Board continued its work to simplify the Group, resolve legacy issues, reduce costs and to commence the process for returning further capital to shareholders.

 

As announced on 7 February 2020, our Healthcare Services division in Canada was sold for an initial cash consideration of Canadian $36.2m (£20.8m) on a cash and debt free basis with up to a further C$0.8m (£0.5m) conditional on the business generating target revenues in the first year after its acquisition.

 

A number of commercial disputes were resolved in the year, the most significant of which was the High Court claim issued by Slater and Gordon (UK) 1 Limited ("S&G"). As announced on 21 October 2019, the settlement provided for £11m of the £50m held in escrow to be released to S&G with the balance of £39m and accrued interest being released to Watchstone.

 

Cash and term deposits on 31 December 2019 (excluding cash within businesses classified as held for sale) totalled £71.6m. Total cash following completion of the sale of the Healthcare Services division, is approximately £90m representing approximately 195 pence per share.

 

Capital return

 

Watchstone will now proceed with plans for a further Court approved, capital repayment to shareholders and further details will be announced in due course. Subject to shareholder approval, completion of the necessary working capital and creditor analysis (including contingent creditors) and the Court timetable, the current plan is to return at least £50m (representing at least 110p per share) before the end of June 2020. The timetable is anticipated to be slightly longer than usual given the need to complete the audit in advance of the return.

 

As further matters are resolved, the Company will seek to return additional cash to shareholders.

 

ingenie

 

Following the sale of the Healthcare Services division, Watchstone now retains one remaining operating business, ingenie. Consistent with our announcement at the half year, ingenie's retail business continued to face difficult market conditions in 2019, but significant changes have been made to increase competitiveness which are now bearing fruit with daily new policy sales at their highest levels for a number of years.

 

In November 2019, ingenie successfully launched its new self-fit proposition making its offering ever more competitive.

 

Legacy matters

 

The SFO investigation continues and we are cooperating fully. It remains the only regulatory inquiry to which the Group is subject.

 

Whilst we understand that the previously threatened class action litigation first announced in September 2015 has been abandoned, a firm purporting to act for a group of twelve individuals (some of whom participated in the original threatened litigation) has recently written a "Notice of intended claim" to the Company ("Notice"). The Notice relates to potential pursuit of a claim arising under section 90A and Schedule 10A of the Financial Services and Markets Act 2000. However, it provides no information to support the validity or valuation of the individual prospective claimants' claims, which they would be required to prove in due course in any litigation. The Company will vigorously defend all such claims if so brought.

 

2020 outlook

 

The Group's stated strategy remains to ultimately divest of its operating businesses, resolve all legacy issues and return as much capital as possible to shareholders.

 

The Board hopes that 2020 will see significant further progress to the final resolution of the Group's historic matters and a substantial return of capital to shareholders in at least one distribution (as referred to above).

 

For further information:

Watchstone Group plc 

 

 

Tel: 03333 448048

WH Ireland Limited, Nominated Adviser and broker

 

Chris Hardie

Lydia Zychowska

Tel: 020 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKZGGZLLNGGZM
Date   Source Headline
9th Sep 20157:00 amRNSAcquisition of remaining 50.1% of PT Healthcare
7th Sep 20157:00 amRNSBoard appointment
2nd Sep 201512:10 pmRNSResult of AGM
24th Aug 20155:49 pmRNSTR-1: Notification of major interest in shares
18th Aug 20157:00 amRNSRegulatory update
17th Aug 20157:00 amRNSBoard appointment/Change of Nominated Adviser
6th Aug 20157:30 amRNSRestoration - Quindell plc
5th Aug 20152:51 pmRNSRegulatory update
5th Aug 201512:41 pmRNSStatement from AIM Regulation on Quindell PLC
5th Aug 201512:28 pmRNSReview Panel Finding
5th Aug 201511:40 amRNS2014 Results Announcement - Part 2
5th Aug 201511:40 amRNS2014 Results Announcement - Part 1
29th Jun 20157:00 amRNSStatement re. temporary suspension and update
24th Jun 20158:37 amRNSStatement from the FCA on Quindell PLC
24th Jun 20158:00 amRNSStatement re. temporary suspension and update
24th Jun 20157:55 amRNSSuspension - Quindell plc
29th May 201511:35 amRNSCompletion of Disposal
22nd May 20158:00 amRNSDisposal Update
19th May 20157:00 amRNSIssue of Shares
30th Apr 201511:43 amRNSDisposal Update
17th Apr 201510:50 amRNSResult of General Meeting and Disposal Update
14th Apr 20157:00 amRNSBoard Appointment
1st Apr 20153:45 pmRNSRestoration - Quindell Plc
1st Apr 20153:15 pmRNSShareholder Circular Correction
1st Apr 201510:52 amRNSN05/15 - Cancellation of trades
1st Apr 201510:08 amRNSDecision with Regard to Trade Cancellation
1st Apr 20159:40 amRNSSuspension - Quindell Plc
30th Mar 20153:03 pmRNSPosting of Circular and Notice of EGM
30th Mar 20157:05 amRNSProposed sale of Professional Services Division
16th Mar 201511:22 amRNSPress speculation
13th Mar 201512:00 pmRNSIssue of Equity
5th Mar 20153:50 pmRNSHolding(s) in Company
5th Mar 20157:00 amRNSUpdate and Issue of Equity
27th Feb 20157:00 amRNSUpdate
23rd Feb 20157:06 amRNSUpdate regarding discussions with Slater & Gordon
18th Feb 20155:43 pmRNSNotification of major interest in shares
16th Feb 20152:14 pmRNSNotification of major interest in shares
11th Feb 20155:52 pmRNSNotification of major interest in shares-Amendment
11th Feb 20155:36 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARESi
2nd Feb 201512:26 pmRNSPress speculation
22nd Jan 20154:41 pmRNSPress speculation
12th Jan 201511:00 amRNSGrant of options
12th Jan 20157:00 amRNSUpdate and Board appointments
9th Jan 201511:09 amRNSPress Speculation
7th Jan 20157:00 amRNSNotification of Major Interest in Shares
2nd Jan 20157:00 amRNSUpdate
22nd Dec 20144:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20144:35 pmRNSPrice Monitoring Extension
10th Dec 20143:16 pmRNSContract updates
10th Dec 20142:25 pmRNSNotification of change in major interest of shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.